Back
abrdn Life Sciences Investors Vs. Triumph Financial Industry Stock Comparison
Buy
58
HQL
abrdn Life Sciences Investors
Last Price:
14.07
Seasonality Move:
-1.02%
Sell
48
TFIN
Triumph Financial
Last Price:
76.04
Seasonality Move:
14.47%
Buy
58
abrdn Life Sciences Investors (HQL)
is a Buy
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $14.19. The Score for HQL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- HQL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
- The current Triumph Financial [TFIN] share price is $77.07. The Score for TFIN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $14.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing slight selling pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $77.07
The current trend is moderately bullish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 66.42 | Buy |
| Chaikin Money Flow: | -15441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.38 - 13.98) | Buy |
| Bollinger Bands (100): | (13.24 - 13.98) | Buy |
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 56.06 | Buy |
| Chaikin Money Flow: | 91022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.94 - 76.64) | Buy |
| Bollinger Bands (100): | (72.35 - 77.47) | Buy |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.87 | Buy |
| 20-day SMA: | 13.67 | Buy |
| 50-day SMA: | 13.55 | Buy |
| 200-day SMA: | 13.15 | Buy |
| 8-day EMA: | 13.91 | Buy |
| 20-day EMA: | 13.78 | Buy |
| 50-day EMA: | 13.65 | Buy |
| 200-day EMA: | 13.48 | Buy |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.85 | Buy |
| 20-day SMA: | 74.74 | Buy |
| 50-day SMA: | 73.79 | Buy |
| 200-day SMA: | 71.88 | Buy |
| 8-day EMA: | 76.24 | Buy |
| 20-day EMA: | 75.29 | Buy |
| 50-day EMA: | 74.73 | Buy |
| 200-day EMA: | 71.96 | Buy |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.44 per share, and an increase next year of $1.18 per share.
abrdn Life Sciences Investors Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Triumph Financial Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||